2-(4-氯-苯基)-辛烷 | 105824-44-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-氯-苯基)-辛烷
• 英文名称: 1-chloro-4-(octan-2-yl)benzene
• 英文别名: Methyl-hexyl-<4-chlor-phenyl>-methan；2-(4-chloro-phenyl)-octane；2-(4-Chlor-phenyl)-octan；1-Chloro-4-octan-2-ylbenzene
• CAS: 105824-44-0
• 化学式: C₁₄H₂₁Cl
• 分子量: 224.774
• InChiKey: FHPAGMJXUBCVGL-UHFFFAOYSA-N

物化性质

• 沸点：
  106-108 °C(Press: 3 Torr)
• 密度：
  0.9553 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  2-(4-氯-苯基)-辛烷 在 ammonium hydroxide 、 copper(l) chloride 作用下， 生成 4-(octan-2-yl)aniline
  参考文献：
  名称：

  Nikolenko,L.N. et al., Journal of general chemistry of the USSR, 1961, vol. 31, p. 1172 - 1175

  摘要：

  DOI：
• 作为产物：
  描述：

  4-chloro-phenyl-bis(methylseleno)methane 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 1.0h， 生成 2-(4-氯-苯基)-辛烷
  参考文献：
  名称：

  芳族醛和酮羰基双二烷基化的新方法

  摘要：

  通过使用硒方法可以有效地实现标题转化，该方法涉及芳基硒缩醛和苄基硒化物的顺序还原烷基化。

  DOI：

  10.1016/s0040-4039(00)84356-7

文献信息

• Iron(II)-Catalyzed Site-Selective Functionalization of Unactivated C(sp³ )−H Bonds Guided by Alkoxyl Radicals
  作者：Honghao Guan、Shutao Sun、Ying Mao、Lei Chen、Ran Lu、Jiancheng Huang、Lei Liu

  DOI：10.1002/anie.201806434

  日期：2018.8.27

  for site‐selective functionalization of unactivated methylene and methine C−H bonds enabled by an FeII‐catalyzed redox process is described. The mild, expeditious, and modular protocol allows efficient remote aliphatic fluorination, chlorination, amination, and alkynylation of structurally and electronically varied primary, secondary, and tertiary hydroperoxides with excellent functional‐group tolerance

  描述了一种通过Fe II催化的氧化还原过程实现未活化的亚甲基和次甲基CH键的位点选择性官能化的烷氧基自由基导向策略。温和，快捷和模块化的协议允许对结构和电子形式不同的伯，仲和叔氢过氧化物进行高效的远程脂肪族氟化，氯化，胺化和炔基化反应，并具有出色的官能团耐受性。还演示了由有氧CH氧化引发的非氧化烷烃底物的单锅1,4-羟基官能化的应用。
• Method for producing an aromatic compound having an alkyl group with at least three carbon atoms
  申请人：TORAY INDUSTRIES, INC.

  公开号：EP0985649A2

  公开（公告）日：2000-03-15

  Aromatic compounds having an alkyl group with at least 3 carbon atoms are produced in a process comprising at least one of the following steps: (1) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a zeolite-containing catalyst in a liquid phase in the presence of hydrogen therein, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (2) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a catalyst containing zeolite and containing rhenium and/or silver, in a liquid phase, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (3) a step of contacting a halogenated aromatic compound having an alkyl group with at least 3 carbon atoms, with an acid-type catalyst, thereby isomerizing the compound; and (4) a step of treating a mixture of isomers of an aromatic compound having an alkyl group with at least 3 carbon atoms, with a zeolite adsorbent that contains at least one exchangable cation selected from alkali metals, alkaline earth metals, lead, thallium and silver, thereby separating a specific isomer from the isomer mixture through adsorption.

  具有至少 3 个碳原子烷基的芳香族化合物的生产工艺至少包括以下一个步骤： (1) 将含有至少 3 个碳原子的支链烷基的芳香族化合物的起始原料在液相中与含沸石的催化剂在氢存在的情况下接触，从而改变烷基的碳原子与化合物的芳香环键合的位置； (2) 将含有芳香族化合物的起始原料与含沸石和含铼和/或银的催化剂在液相中接触，该芳香族化合物具有至少 3 个碳原子的支链烷基，从而改变烷基碳原子与化合物芳香环键合的位置； (3) 将具有至少 3 个碳原子的烷基的卤代芳香族化合物与酸型催化剂接触，从而使该化合物异构化；以及 (4) 用沸石吸附剂处理具有至少 3 个碳原子的烷基的芳香族化合物的异构体混合物，该沸石吸附剂含有至少一种选自碱金属、碱土金属、铅、铊和银的可交换阳离子，从而通过吸附从异构体混合物中分离出特定的异构体。
• Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10399933B2

  公开（公告）日：2019-09-03

  There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

  本发明公开了调节或抑制吲哚胺-2,3-二氧化酶（IDO）酶活性的式(I)化合物、含有所述化合物的药物组合物以及利用本发明化合物治疗增殖性疾病（如癌症、病毒感染和/或炎症性疾病）的方法。
• Some Boron Trifluoride Catalyzed Alkylations of Halobenzenes¹
  作者：G. F. Hennion、V. R. Pieronek

  DOI：10.1021/ja01264a009

  日期：1942.12
• CLAREMBEAU, M.;KRIEF, A., TETRAHEDRON LETT., 1986, 27, N 15, 1719-1722
  作者：CLAREMBEAU, M.、KRIEF, A.

  DOI：——

  日期：——